Endovesical Bacillus Calmette-Guérin for Nonmuscle Invasive Bladder Cancer in Kidney Transplant Recipients: Is It Safe and Efficacious?
Exp Clin Transplant
.
2022 Aug;20(8):789-791.
doi: 10.6002/ect.2022.0154.
Authors
Thomas Prudhomme
1
,
Iulia Andras
,
Romain Boissier
,
Riccardo Campi
,
Vital Hevia
,
Angelo Territo
,
European Association Of Urology Young Academic Urologist Kidney Transplant Group
Affiliation
1
From the Department of Urology, Kidney Transplantation and Andrology, Rangueil Hospital, Toulouse, France.
PMID:
36044363
DOI:
10.6002/ect.2022.0154
No abstract available
Publication types
Letter
MeSH terms
BCG Vaccine / adverse effects
Humans
Kidney Transplantation* / adverse effects
Neoplasm Invasiveness
Neoplasm Recurrence, Local
Treatment Outcome
Urinary Bladder Neoplasms* / surgery
Substances
BCG Vaccine